The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term survival outcomes of patients (pts) with relapsed or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) treated with brexucabtagene autoleucel (brexu-cel) in ZUMA-3.
 
Olalekan O. Oluwole
Honoraria - Kite, a Gilead company
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Allogene Therapeutics; Autolus Therapeutics; CARGO Therapeutics; Caribou Biosciences; Epizyme; Gilead Sciences; Kite/Gilead; Nektar; Novartis; TG Therapeutics
Research Funding - Kite, a Gilead company (Inst)
Travel, Accommodations, Expenses - Gilead Sciences
 
Armin Ghobadi
Honoraria - Kite, a Gilead Company
Consulting or Advisory Role - Amgen; Atara Biotherapeutics; Bristol-Myers Squibb; Crispr Therapeutics; Kite, a Gilead Company; WUGEN, Inc.
Research Funding - Amgen; Genentech; Kite, a Gilead Company
 
Ryan Daniel Cassaday
Employment - Seagen (I)
Stock and Other Ownership Interests - Seagen (I)
Honoraria - Kite, a Gilead company; Pfizer
Consulting or Advisory Role - Amgen; Autolus; Jazz Pharmaceuticals; Kite/Gilead; Pfizer
Research Funding - Amgen (Inst); Incyte (Inst); Kite, a Gilead company (Inst); Pfizer; SERVIER (Inst); Vanda Pharmaceuticals
Travel, Accommodations, Expenses - Kite, a Gilead company
Other Relationship - Autolus; Pepromene
 
Jae H. Park
Consulting or Advisory Role - AstraZeneca; Kite, a Gilead Company; Novartis
Research Funding - Amgen; Genentech; Juno Therapeutics
 
Roch Houot
Honoraria - ADC Therapeutics; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Kite, a Gilead Company; MSD; Novartis
Consulting or Advisory Role - Gilead Sciences; Kite, a Gilead Company,
 
Aaron Logan
Consulting or Advisory Role - Amgen; Kite, a Gilead company; Pfizer; Sanofi; Takeda
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Autolus (Inst); Kadmon (Inst); Kite, a Gilead company (Inst); Pharmacyclics (Inst); Talaris (Inst)
Travel, Accommodations, Expenses - Amgen
 
Nicolas Boissel
Honoraria - Amgen; ARIAD/Incyte; Astellas Pharma; Novartis; SERVIER
Consulting or Advisory Role - Amgen; Novartis; SERVIER
Research Funding - Amgen; Novartis
Expert Testimony - Amgen
 
Thibaut Leguay
Honoraria - Gilead Sciences; Incyte; SERVIER
Expert Testimony - Clinigen Healthcare
 
Michael Russell Bishop
Honoraria - Bristol-Myers Squibb/Celgene/Juno; Incyte; Incyte; Sanofi/Aventis
Consulting or Advisory Role - Arcellx; Autolus; BMS; Chimeric Therapeutics; crispr therapeutics; In8Bio; Iovance Biotherapeutics; Johnson & Johnson/Janssen; Kite, a Gilead company; Novartis; Sana Biotechnology
Speakers' Bureau - Abbvie/Genmab; ADC Therapeutics; Bristol-Myers Squibb; Incyte; Kite, a Gilead company; Sanofi; SERVIER
Research Funding - Arcellx (Inst); crispr therapeutics (Inst); Iovance Biotherapeutics (Inst); Kite, a Gilead company (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - BMS; Kite/Gilead; Novartis
 
Max S. Topp
Consulting or Advisory Role - Abbvie; AstraZeneca; BMS; Genmab; Genmab; Iovance Biotherapeutics; Janssen; Kite/Gilead; Roche
Research Funding - Kite, a Gilead company (Inst); Regeneron (Inst); Roche (Inst)
 
Kristen M. O'Dwyer
No Relationships to Disclose
 
Maria R. Baer
Research Funding - Abbvie; Ascentage Pharma; Kite, a Gilead Company; Kura Oncology; Takeda
 
Gary J. Schiller
Stock and Other Ownership Interests - Amgen; Bristol-Myers Squibb; Johnson & Johnson
Consulting or Advisory Role - Abbvie; Agios; Astellas Pharma; Autolus Therapeutics; Bristol-Myers Squibb/Celgene; Celgene; Incyte; Jazz Pharmaceuticals; Novartis; Ono Pharmaceutical; Rigel
Speakers' Bureau - Abbvie; Agios; Amgen; Astellas Pharma; Blueprint Medicines; Bristol-Myers Squibb; Incyte; Jazz Pharmaceuticals; Karyopharm Therapeutics; Kite, a Gilead company; Rigel; Sanofi; Seattle Genetics/Astellas; Stemline Therapeutics
Research Funding - Abbvie; Actinium Pharmaceuticals; Actuate Therapeutics; Agios; Amgen; Aptevo Therapeutics; Arog; Astellas Pharma; AVM Biotechnology; Bio-Path Holdings; Biomea Fusion; Biosight; Bristol-Myers Squibb/Celgene; Celator; Cellectis; Celularity; Cogent Biosciences; Constellation Pharmaceuticals; Cullinan Oncology; Daiichi Sankyo; Deciphera; Delta-Fly Pharma; ElevateBio; Fate therapuetics; FORMA Therapeutics; Fujifilm; Gamida Cell; Genentech/Roche; Geron; glycomimetics; Immune-Onc Therapeutics; Incyte; Jazz Pharmaceuticals; Karyopharm Therapeutics; Kite, a Gilead company; Kronos Bio; Kura Oncology; Loxo; Marker Therapeutics; Mateon Therapeutics; Novartis; Onconova Therapeutics; Ono Pharmaceutical; Pfizer; PrECOG; REGiMMUNE; REGiMMUNE; Samus Therapeutics; Sangamo Bioscience; Sanofi; Sellas Life Sciences; Stemline Therapeutics; Syros Pharmaceuticals; Syros Pharmaceuticals; Takeda; Tolero Pharmaceuticals; Trovagene
 
Mehrdad Abedi
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Speakers' Bureau - Abbvie; Bristol-Myers Squibb; Celgene; Kite, a Gilead Company
 
Monique C. Minnema
Consulting or Advisory Role - CDR-life (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst)
Speakers' Bureau - Celgene/Bristol-Myers Squibb (Inst); Janssen medical Affairs (Inst); Siemens Healthcare Diagnostics (Inst)
Research Funding - BeiGene (Inst)
Travel, Accommodations, Expenses - Janssen medical Affairs
 
Patrick J. Stiff
Honoraria - Morphosys
Consulting or Advisory Role - crispr therapeutics
Research Funding - Actinium Pharmaceuticals (Inst); Amgen (Inst); Gamida Cell; Incyte; Kite, a Gilead company; Macrogenics (Inst); Pfizer (Inst); Seagen
 
Lang Zhou
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Abbvie
 
Rubina Siddiqi
Employment - Amgen; Kite, a Gilead Company
Stock and Other Ownership Interests - Amgen; Gilead Sciences
Travel, Accommodations, Expenses - Kite/Gilead Sciences
 
Rita Damico Khalid
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Kite, a Gilead Company
Travel, Accommodations, Expenses - Kite, a Gilead Company
 
Bijal D. Shah
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Autolus; BeiGene; Bristol-Myers Squibb; Century Therapeutics; Deciphera; Jazz Pharmaceuticals; Kite, a Gilead Company; Lilly; Novartis; Pfizer; Precision BioSciences; Takeda
Research Funding - Jazz Pharmaceuticals; Kite, a Gilead Company; Servier
Other Relationship - Pepromene